Largest biotech companies in the United States by revenue

Everything the company sold in its latest fiscal year, before any cost is taken off.

Amgen leads the 17 biotech companies in the United States ranked by revenue, at A$55.5B, ahead of Gilead Sciences (A$44.5B) and Biogen (A$14.9B). Figures as of 20 Nov 2026, 23:00 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
17
First
AmgenA$55.5B
Median
A$1.1B
Combined market value
A$1.1T
Countries
1
Not ranked
3no revenue on file

Market values as of .

United States
All sectors
Biotech
AUD
Clear filters
Largest biotech companies in the United States by revenue
#CompanyRevenue ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareA$55.5BA$356BA$658.16 0.15% down 30% up United States
2Gilead SciencesGILD · Health CareA$44.5BA$311.9BA$251.44 0.06% down 31% up United States
3BiogenBIIB · Health CareA$14.9BA$55.7BA$377.08 1.00% up 41% up United States
4Neurocrine BiosciencesNBIX · Health CareA$4.3BA$23BA$227.48 3.84% down 10% up United States
5ExelixisEXEL · Health CareA$3.5BA$23.8BA$97.64 1.82% down 55% up United States
6ModernaMRNA · Health CareA$2.9BA$119.2BA$294.61 2.17% down 740% up United States
7Halozyme TherapeuticsHALO · Health CareA$2.1BA$15.7BA$138.01 1.82% down 32% up United States
8Bio-TechneTECH · Health CareA$1.8BA$17.2BA$109.79 0.04% down 18% up United States
9RepligenRGEN · Health CareA$1.1BA$15.8BA$247.48 3.81% down 5% up United States
10Krystal BiotechKRYS · Health CareA$587.9MA$13.8BA$466.67 2.19% down 49% up United States
11Twist BioscienceTWST · Health CareA$568.9MA$10.6BA$156.10 7.44% down 291% up United States
12Adaptive BiotechnologiesADPT · Health CareA$418.5MA$6.8BA$42.20 0.43% down 51% up United States
13ImmunityBioIBRX · Health CareA$171.2MA$9.7BA$9.10 8.37% down 216% up United States
14Kymera TherapeuticsKYMR · Health CareA$59.2MA$14.9BA$174.21 3.42% down 81% up United States
15CG OncologyCGON · Health CareA$6.1MA$10.7BA$120.06 2.97% down 93% up United States
16Revolution MedicinesRVMD · Health CareA$0A$52.7BA$243.54 1.11% up 125% up United States
17Scholar Rock HoldingSRRK · Health CareA$0A$8.9BA$72.71 4.45% down 25% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.5108 AUD). 3 companies have no revenue on file and are not ranked here.

Questions and answers

Which biotech companies in the United States rank first by revenue?

Amgen (A$55.5B), Gilead Sciences (A$44.5B) and Biogen (A$14.9B) are the top three of the 17 biotech companies in the United States ranked by revenue as of 20 Nov 2026, 23:00 UTC.

How many biotech companies in the United States are in this ranking?

17 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 17 biotech companies in the United States ranked by revenue have a combined market value of A$1.1T as of 20 Nov 2026, 23:00 UTC.

What does ranking by revenue measure?

Everything the company sold in its latest fiscal year, before any cost is taken off.

Cite this page

Funkfolio, “Largest biotech companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=revenue

Underlying data: Yahoo Finance; SEC EDGAR.